Human papillomaviruses (HPVs) cause more than five percent of all human cancers worldwide, yet for many, current treatments are ineffective.
Dohun Pyeon, a Michigan State University professor in the Department of Microbiology and Molecular Genetics (MMG) in the College of Natural Science, is the recipient of a 2023 Strategic Partnership Grant (SPG) from the MSU Research Foundation to support his work on the development of a new immunotherapy for HPV-associated cancers.
SPG funding supports early-stage research projects with a strong potential for high impact in the future. Because projects are often high risk and high reward, the expectation is that many funded projects will not succeed, but that a few major achievements will emerge.
After a competitive application process, as one of just three SPG recipients in 2023, Pyeon will receive $480,000 over three years to help his lab reach its long-term goal of developing an inexpensive immunotherapy.
For the full story, visit natsci.msu.edu